These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36856205)

  • 1. [Identification of key molecules in miRNA-mRNA regulatory network associated with high-grade serous ovarian cancer recurrence using bioinformatic analysis].
    Zhang P; He M; Zeng Y; Cai X
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):8-16. PubMed ID: 36856205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis.
    Tang Q; Wen H; Hu H; Chen X; Xu S; Fan L; Liu L; Li J
    Recent Pat Anticancer Drug Discov; 2024; 19(2):233-246. PubMed ID: 38214360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer.
    Lu X; Li G; Liu S; Wang H; Chen B
    J Ovarian Res; 2021 Jul; 14(1):90. PubMed ID: 34238324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
    Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
    BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian Cancer.
    Flores-Colón M; Rivera-Serrano M; Reyes-Burgos VG; Rolón JG; Pérez-Santiago J; Marcos-Martínez MJ; Valiyeva F; Vivas-Mejía PE
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the clinical significance of ETAR mRNA expression in high-grade serous ovarian cancer and the inhibitory effect of ETAR derived fusion polypeptide on cancer progression].
    Zhang YL; Xia XK; Zhang M
    Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):930-938. PubMed ID: 38123199
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of two miRNAs promotes proliferation, hepatitis B virus amplification, migration and invasion of hepatocellular carcinoma cells: evidence from bioinformatic analysis and experimental validation.
    Liu Y; Cao Y; Cai W; Wu L; Zhao P; Liu XG
    PeerJ; 2020; 8():e9100. PubMed ID: 32377460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
    Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
    BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key elements involved in Epstein-Barr virus-associated gastric cancer and their network regulation.
    Jing JJ; Wang ZY; Li H; Sun LP; Yuan Y
    Cancer Cell Int; 2018; 18():146. PubMed ID: 30258285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP3K3.
    Zhang L; Zhang Y; Wang S; Tao L; Pang L; Fu R; Fu Y; Liang W; Li F; Jia W
    Am J Transl Res; 2020; 12(3):875-888. PubMed ID: 32269720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
    Liu F; Zhang G; Lv S; Wen X; Liu P
    J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering miRNA-mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of
    Biegała Ł; Kołat D; Gajek A; Płuciennik E; Marczak A; Śliwińska A; Mikula M; Rogalska A
    Cells; 2024 May; 13(10):. PubMed ID: 38786089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
    Xue B; Li S; Jin X; Liu L
    BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-451a suppresses the proliferation and migration of high-grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathway.
    Liu S; Wang K; Zhao Z; Pang Y; Liu F; Wang P; Wang Z; Yang X
    J Gene Med; 2024 Jan; 26(1):e3649. PubMed ID: 38282155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
    Xu H; Mao HL; Zhao XR; Li Y; Liu PS
    J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A.
    Feng S; Luo S; Ji C; Shi J
    World J Surg Oncol; 2020 Dec; 18(1):315. PubMed ID: 33261630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients.
    Petersen PHD; Lopacinska-Jørgensen J; Høgdall CK; Høgdall EV
    Mol Biol Rep; 2023 Dec; 50(12):10235-10247. PubMed ID: 37934368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer.
    Niemira M; Erol A; Bielska A; Zeller A; Skwarska A; Chwialkowska K; Kuzmicki M; Szamatowicz J; Reszec J; Knapp P; Moniuszko M; Kretowski A
    Sci Rep; 2023 Nov; 13(1):19287. PubMed ID: 37935712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
    Lee H; Park CS; Deftereos G; Morihara J; Stern JE; Hawes SE; Swisher E; Kiviat NB; Feng Q
    World J Surg Oncol; 2012 Aug; 10():174. PubMed ID: 22925189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.